June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
In vitro effects of Resveratrol and Resvega to Endothelial Murine Cells Culture
Author Affiliations & Notes
  • Dariusz Rokicki
    Thea Polska, Warsaw, Poland
  • Robert Zdanowski
    Department of Regenerative Medicine, Military Institute of Hygiene and Epidemiology, Warsaw, Poland
  • Slawomir Lewicki
    Department of Regenerative Medicine, Military Institute of Hygiene and Epidemiology, Warsaw, Poland
  • Monika Lesniak
    Department of Regenerative Medicine, Military Institute of Hygiene and Epidemiology, Warsaw, Poland
  • Milena Suska
    Department of Regenerative Medicine, Military Institute of Hygiene and Epidemiology, Warsaw, Poland
  • Ewa Skopinska-Rozewska
    Pathology Department, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland
  • Piotr Skopinski
    Department of Histology and Embryology, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland
  • Footnotes
    Commercial Relationships Dariusz Rokicki, Thea PL (E); Robert Zdanowski, None; Slawomir Lewicki, None; Monika Lesniak, None; Milena Suska, None; Ewa Skopinska-Rozewska, None; Piotr Skopinski, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4298. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Dariusz Rokicki, Robert Zdanowski, Slawomir Lewicki, Monika Lesniak, Milena Suska, Ewa Skopinska-Rozewska, Piotr Skopinski; In vitro effects of Resveratrol and Resvega to Endothelial Murine Cells Culture . Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4298.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Pathological angiogenesis plays an essential role in the pathomechanism of numerous disorders, including e.g.exudative age-related macular degeneration (AMD) or proliferative diabetic retinopathy. Since the crucial role is played by the angiogenesis in these conditions, there has been increased interest in evaluating potential anti-angiogenic agents in their management. The aim of our study was to assess in vitro the influence of resveratrol and resveratrol based formula (Resvega) on proliferation, migration and invasion of immortalized murine endothelial cell line from peripheral lymph node HEC clone a10.

Methods: Proliferation of endothelial cells was estimated using MTT, and neutral red assay (NR). MTT assay evaluates viability based on the conversion of MTT into formazan crystals by living cells, which determines mitochondrial activity, whereas NR uptake is directly proportional to the number of viable cells actively accumulating dye neutral red in lysosomes.<br /> In addition, cell migration and cell invasion assays were examined using BD FluoroBlok™ fluorescence blocking membranes in 24-well plates. Resveratrol (1, 5, 10, 50 or 100 µM, Sigma Aldrich) or Resvega (1, 5, 10, 50 or 100 µM, Laboratoires Thea) were added to the lower chamber. As a control was used culture medium without resveratrol or Resvega, and as a negative control - FBS-free culture medium. Statistical analysis of the results was performed with two-way (proliferation) and one-way (migration and invasiveness) ANOVA with Tukey’s Multiple Comparison Test (GraphPadPrism).

Results: Resveratrol and Resvega were shown to inhibit the proliferation of the endothelial cells in MTT (concentration-dependently) and NR (at highest concentrations only) assays, and both agents at the concentration of 50 μM significantly inhibited migration of endothelial cells. A concentration-dependent decrease in invasion potential of endothelial cells incubated with resveratrol or Resvega 10 μM and 50 μM was detected.

Conclusions: These promising in vitro results might encourage investigators to testify efficacy and safety of resveratrol based products as e.g. Resvega, more extensively in the clinical practice.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×